Skip to main content

Table 1 Patient characteristics and results of brachial artery flow-mediated dilation test

From: Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan

No.

Age

Gender

Prior treatment

Give up smoking

Months F/u

Pre-treatment clinical results

Post-treatment clinical results

BAFMD Pre-treatment

BAFMD Post-treatment

BAFMD 3 months after

1

35

F

PG + LS

YES

20

Ulcer in toe

Healing

1.1

6.7

11.6

2

36

F

PG

YES

40

Ulcer in toes

Healing

0

5.2

17.1

3

32

M

PG

NO

21

Ulcer in fingers

Healing

1.5

6.9

10.8

4

46

F

PG

NO

20

Ulcer in fingers

Healing

0.8

6.5

12.3

5

47

M

PG

NO

12

Pain at rest

Pain relief Claudicates 300 m

2.3

7.1

12.6

6

46

M

PG

NO

11

Ulcer in toes

Healing

3.5

8.9

9.8

7

29

M

PG

NO

35

Ulcer in toes

Healing

1.2

4.1

9.6

8

39

F

BP (occlude)

NO

31

Ulcer in toe

Healing

0.3

5.9

11.3

9

45

M

BP (occlude)

NO

18

Ulcer in toe

Ulcer Improvement

0.9

4.9

10.1

10

39

F

PG + LS

YES

16

Ulcer in forefoot

ICA

3.7

7.7

16.9

11

22

M

PG + LS

NO

13

Ulcer in toes

Healing. Amp. 3rd toe

4.1

7.8

17.9

12.a

49

M

2 BP (permeable) + PG

YES

12

Ulcer in toe

Healing

2.3

6.9

12.3

12.b

49

M

PG

YES

12

Ulcer in fingers

Ulcer Improvement

2.3

6.9

12.3

  1. Abbreviations: BAFMD: brachial artery flow-mediated dilation test; ICA: Infracondylar amputation; Amp: Amputation; BP: Bypass; F: Female; M: Male; PG: Prostaglandins; LS: Lumbar Sympathectomy; F/u: follow-up.